SEC Form 4 · accession 0001104659-18-010876
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jamie Mark Grooms
Director
Period of report
Feb 16, 2018
Accepted (ET)
Feb 20, 2018 · 7:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Feb 16, 2018 | S | 26,655 | $27.35 | D | 99,601 | I | See Footnote |
| Common StockF2,F3 | Feb 20, 2018 | S | 36,740 | $27.90 | D | 62,861 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.10 to $27.65. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.10 to $28.20. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee.
- F4The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017.